0001209191-23-026744.txt : 20230502 0001209191-23-026744.hdr.sgml : 20230502 20230502190458 ACCESSION NUMBER: 0001209191-23-026744 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230429 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Teehan Brendan CENTRAL INDEX KEY: 0001891900 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 23881109 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-29 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001891900 Teehan Brendan C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 EVP, COO, Head of Commercial 0 Common Stock 2023-04-29 4 M 0 1567 0.00 A 10035 D Common Stock 2023-05-01 4 S 0 548 21.18 D 9487 D Restricted Stock Units 2023-04-29 4 M 0 1567 0.00 D Common Stock 1567 0 D The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. 50% of the shares subject to the restricted stock units vest on each of April 29, 2022 and April 29, 2023. /s/ Austin D. Kim, Attorney-in-Fact 2023-05-02